Browse Categories
Search
Stay In Touch
Login
|
|
Home > All Products > CBI and Applied Clinical Trials 6th Annual Cardiovascular Risk Assessment - Online Compendium
CBI and Applied Clinical Trials 6th Annual Cardiovascular Risk Assessment - Online Compendium
|
Item Number: C12Q102
Bridging Preclinical to Clinical - Assess Cardiovascular Risk Early in Drug Development
Current Trends in CV Risk Assessment
Non-Clinical Assay Performance - Effectively Guiding Translation to Clinic
Potent Ikr Blockade by a Compound in Early R&D Does Not Necessarily Mean Early Death-CASE STUDY
Strategies for CV Risk Assessment in Compound Selection and Translation to Clinic
Assess Surrogates of Clinical Cardiotoxicity Using Stem Cell-Derived Cardiomyocytes-CASE STUDY
Innovative Approaches for Advance Risk Monitoring
Utilize Troponin Measurements for Cardiotoxicity Monitoring and Management
How Can the Thorough QT Study Be Replaced - Implementing Novel Approaches and High Precision Techniques in Early Clinical Development
Blood Pressure (BP) Evaluation and Drug-Induced Blood Pressure Changes
A Case of Advanced Integrated QRS Analysis for Early Clinical CV Risk Assessment-CASE STUDY
Baseline Correction in Parallel TQT Studies
Develop a Successful Cardio-Oncology Program
Define What Magnitude of Change in Heart Rate (HR) Should Be Considered a Clinical Concern
Academia and Industry Collaboration for CV Risk Mitigation |
|
|
|